REPLIMUNE GROUP INC (REPL:NASDAQ)
$4.68 -0.02 (-0.4255%)
Analysed REPLIMUNE GROUP INC (REPL:NASDAQ) News Sources
Replimune Gets Second FDA CRL for Melanoma Drug BLA, Stock Crashes
13-04-2026
yahoo.com
Sector Update: Health Care Stocks Softer Monday Afternoon
13-04-2026
yahoo.com
Replimune Plans Layoffs After FDA Rejects Cancer Therapy. The Stock Hits an All-Time Low.
13-04-2026
yahoo.com
Top Midday Decliners
13-04-2026
yahoo.com
Sector Update: Health Care Stocks Advance Late Afternoon
13-04-2026
yahoo.com
Replimune Group (REPL) Is Down 75.0% After FDA Rejects RP1 Melanoma BLA Over Trial Design Concerns
15-04-2026
yahoo.com
Jefferies Sees Reduced Visibility for Replimune Group, Inc. (REPL) Following FDA Decision
17-04-2026
yahoo.com
Replimune to Present at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
27-04-2026
yahoo.com
Oncolytics Biotech Reports Data in Colorectal Cancer Study
06-05-2026
yahoo.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
13-05-2026
yahoo.com
What is the current price of REPLIMUNE GROUP INC (REPL:NASDAQ)?
The current price of REPLIMUNE GROUP INC (REPL:NASDAQ) is $4.68.
REPLIMUNE GROUP INC (REPL:NASDAQ) absolute price change since previous trading day?
The absolute price change of REPLIMUNE GROUP INC (REPL:NASDAQ) since the previous trading day is $-0.02.
REPLIMUNE GROUP INC (REPL:NASDAQ) percentage price change since previous trading day?
The percentage price change of REPLIMUNE GROUP INC (REPL:NASDAQ) since the previous trading day is -0.4255%.
What is the most recent average sentiment score for REPLIMUNE GROUP INC (REPL:NASDAQ)?
The most recent average sentiment score for REPLIMUNE GROUP INC (REPL:NASDAQ) is 53 out of 100.
What is the most recent average sentiment for REPLIMUNE GROUP INC (REPL:NASDAQ)?
The most recent sentiment for REPLIMUNE GROUP INC (REPL:NASDAQ) is .
SEC-8K** Filing Available For REPLIMUNE GROUP INC (REPL:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.